Pfizer posts surprise profit as US returns fewer courses of COVID pill
Pfizer reported a surprise quarterly profit on Tuesday, helped by its cost-cutting measures and as the U.S. government returned fewer courses of COVID treatment Paxlovid than it had expected. The U.S. drugmaker recorded a $3.5 billion revenue reversal related to the treatment during the period for…
#pfizer #revenues #comirnaty #rsv